SCHEMBL3476312

SCHEMBL3476312

CCc1cc(Nc2cc(=O)[nH]c(=O)n2CCCCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3476316 0.88 — —
SCHEMBL3476311 0.79 CCR1 (0.37) —
SCHEMBL7698417 0.75 UNG (0.52) —
SCHEMBL6773757 0.72 UNG (0.47) —
Hydrochloric Acid SCHEMBL11506955 0.72 DRD2 (0.51) —
SCHEMBL7037823 0.72 — —
SCHEMBL11508308 0.69 DRD2 (0.56) —
SCHEMBL11508526 0.69 DRD2 (0.52) —
SCHEMBL11507328 0.69 HTR7 (0.66) —
SCHEMBL11997019 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010134939-A2 MAMMALIAN GENES INVOLVED IN INFECTION Zirus, Inc. (US) 2010-11-25 — — WO disclosed
WO-2003011297-A1 N3-SUBSTITUTED 6-ANILINOPYRIMIDINES AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS UNIVERSITY OF MASSACHUSETTS (US) 2003-02-13 — — WO disclosed
Send feedback